Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
Top Cited Papers
- 1 November 2003
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 362 (9395), 1527-1535
- https://doi.org/10.1016/s0140-6736(03)14739-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- The Study on Cognition and Prognosis in the Elderly (SCOPE)Journal Of Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid AtherosclerosisCirculation, 2002
- Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)The American Journal of Cardiology, 2001
- Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly HypertensivesHypertension, 1999
- The Verapamil in Hypertension and Atherosclerosis Study (VHAS)Journal Of Hypertension, 1998
- Reliable and unbiased assessment of the effects of calcium antagonistsJournal Of Hypertension, 1997
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985